Author

Oluwafemi Ezekiel Kale

Olabisi Onabanjo UniversityORCID 0000-0003-2965-1723Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:rat· 1

Frequent Co-Authors

Ifabunmi Oduyemi OsonugaiD· 1 shared Martins EkoriD· 1 shared Miyase Gözde GündüziD· 1 shared Olufunsho Awodele· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ifabunmi Oduyemi OsonugaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintSep 21, 2025

A new 1,4-Dihydropyridine-Based L-/T-Type Calcium Channel Inhibitor, HM12, Provides in Vivo and in silico Cardioprotective Effects in Doxorubicin-Treated Rats

Oluwafemi Ezekiel Kale, Miyase Gözde Gündüz, Ifabunmi Oduyemi Osonuga…·Martins Ekor

This study evaluates HM12, a calcium channel inhibitor, for cardioprotective effects against doxorubicin toxicity in rats, showing improved antioxidant status and reduced inflammation.

DOI 10.1101/2025.09.21.677599

ratexperimental assay

𝕏 PostBluesky